Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are widely used clinically as blood glucose-lowering agents in the treatment of type 2 diabetes mellitus (T2DM), and these drugs also have a weight-lowering effect15. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.